A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
PHASE4
This study will assess the effect of omalizumab on exercise capacity, physi...
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
N/A
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
PHASE4
In patients with at least moderate persistent allergic asthma controlled wi...